oNElAB MEMO CALLOUT
Annual Report 300
Ebola Podcast
Society for Hematopathology logo

ASCP and Society for Hematopathology Alliance Expands Opportunities to Improve Health Care

Monday, February 18, 2013

The new alliance between ASCP and the Society for Hematopathology (SH) is producing tangible benefits that will strengthen and enhance the work of both Societies. 

“Association with ASCP brings collaborative vitality to both organizations,” says Society for Hematopathology President Marsha C. Kinney, MD. “The large and experienced ASCP staff provides in-depth professional management and membership services and support for our educational activities.”

“Association with ASCP brings collaborative vitality to both organizations. The large and experienced ASCP staff provides in-depth professional management and membership services and support for our educational activities.”
—Marsha C. Kinney, MD,
President, Society for Hematopathology

The collaboration with SH strengthens both Societies’ shared missions of interdisciplinary education, scientific discovery, and advocacy. For example, ASCP has invited SH to appoint one of its members to serve on an ASCP steering committee to develop and implement a new curriculum titled, “The Diagnosis, Classification, and Clinical Care of Myelodysplastic Syndromes (DC3–MDS).” Magdalena Czader, MD, PhD, Director of Hematopathology at Indiana University’s School of Medicine, Indianapolis, and a member-at-large of the SH Executive Committee, has been appointed to this position.

The curriculum will be geared toward pathologists, hematologists, oncologists, and other healthcare providers to help them better diagnose and manage the care of patients with Myelodysplastic syndromes (MDS), a potentially deadly cluster of blood and bone marrow disorders that are difficult to diagnose. In one third of the patients with MDS, the disease transforms into acute myelogenous leukemia (AML), usually within months to a few years. Patients who have MDS are frequently misdiagnosed or diagnosed when cancer is already in the late stages.

“Partnering with important medical societies such as the Society for Hematopathology enhances communication across the healthcare chain and ultimately improves the outcomes of patient care,” said Dr. E. Blair Holladay, ASCP Executive Vice President. “Those outcomes rely on relationships between pathologists, laboratory professionals, and the wide range of sub-specialties within the laboratory.”

Nancie Noie Thompson, Director of Affiliated Organizations at ASCP, is assisting with the management of the SH Annual Executive Committee meeting to be held March 2 in Baltimore, as well as the Society’s business meeting and breakfast meeting for directors of hematopathology fellowship programs the following day. Ms. Thompson was appointed to this position in January to serve as liaison to the leadership of ASCP’s new partner societies and to coordinate ASCP staff support to the societies.

Beginning in 2015, SH and its sister organization, the European Association for Haematopathology (EAHP), will hold their Biennial Hematology Workshop in tandem with the ASCP Annual Meeting, so members can take advantage of the rich content of the ASCP Annual Meetings.  

Dr. Kinney adds, “ASCP is a leader in international health care, and SH members will have expanded opportunities to make a difference in hematology/hematopathology practice and patient care worldwide. As a result of these enhanced support services, SH will be positioned to focus on new academic projects, enhanced fellowship training, and have an expanded presence for advocacy efforts regarding hematopathology practice.”


~/Custom.Templates/NewsroomDetail.aspx